“…This is in line with previous studies, even though four ART-resistance validated mutations (i.e., 446I, 539T, 561H, 625R) have been reported at very marginal proportions in two areas of India (Arunanchal Pradesh, West Bengal) [ 63 – 65 ]. Other pfk13 polymorphisms (189T, 481V, 533A, 549Y, 578S, 579T, 657H, 672S, 675V, and 702N) have been also reported in these two regions and elsewhere (Mizoram, Tripura, Madhya Pradesh, and Assam) [ 63 , 64 , 66 – 68 ]. This implies that ART-resistance has not yet emerged, but molecular surveillance should be continuously carried out in malarious regions in India.…”